PROGRAM SCHEDULE

Use this page to view the abstracts scheduled in the program.

There are two ways to search: you can view each oral or poster session, or you can search for an author's name. Clicking on the Session Reference will expand the view, to show you the abstracts contained in that session. Click on the Abstract Reference Number to view the abstract.

If you are browsing the sessions, you can use the date selection pull-down to select a specific day, or choose Show All to see all sessions.

To search by author name, change the date to Show All unless you wish to limit your search to that author's abstracts on a given day. Enter the author's surname or given name into the name field, and press Search to find all abstracts with an author by that name.

Canadian Neurological Sciences Federation's Congress

SCHEDULE

Date:

Author Name:

Presentation Type:

Word or Phrase:

Showing Records 1 - 25 of 25 [Page: 1 ]

Session#	Date	Time	Room	Session Name
GR	Thu, June 12	09:00 - 12:00	Gatineau Salon	Grand Rounds
GR.1 Cost-effectiveness of multidisciplinary palliative care interventions in advanced Parkinsonism Syndromes GR.2 Circulating plasma cytokines as biomarkers of inflammatory activity in radiologically isolated syndrome and Multiple Sclerosis GR.3 Mortality in tuberous sclerosis complex: current understandings GR.4 EEG biomarkers for Alzheimer’s Disease: a novel automated pipeline for detecting and monitoring disease progression GR.5 Identification of molecular biomarkers of response to combinatorial PARP inhibition and immune checkpoint blockade in IDH-Mutant Gliomas GR.6 Deep brain stimulation of the nucleus accumbens for severe self-injurious behaviour in children: a phase I pilot trial
A	Thu, June 12	08:00 - 09:00	Room 201	Adult Neurology (CNS) Mini-Platforms
Moderator: TBA A.1 Plasma Chitinase 3-like 1 protein levels in people with Radiologically Isolated Syndrome correlate with choroid plexus volume and subcortical grey matter atrophy A.3 Comparison of anterior versus posterior circulation stroke patients undergoing thrombectomy: results from the OPTIMISE registry A.4 Automating gait analysis in children with Cerebral Palsy using an artificial intelligence-augmented pipeline A.6 The clinical validation of a comprehensive neural autoantibodies testing A.7 A novel Xdystonia-parkinsonism gene variant responsive to bilateral GPi DBS: a video case study
B	Thu, June 12	08:00 - 09:00	Room 212	Canadian Stroke Consortium (CSC) Mini-Platforms
Moderator: Michel Shamy B.1 Safety and effectiveness of intravenous thrombolysis for acute stroke patients in the Manitoba TeleStroke Program B.2 Association between age, frailty, and thrombectomy for ischemic stroke B.3 Early motor cortex dysconnectivity and compensatory neuronal reactivity in acute stroke is dependent on the side of stroke B.4 Time to intervention in anticoagulant-associated intracerebral hemorrhage: gaps in care and their effect on hematoma expansion B.5 Does major depression after stroke influence the risk of suicide after stroke? B.6 Location-specific hematoma volume tolerances for spontaneous intracerebral hemorrhage B.7 Rapid Glial Fibrillary Acidic Protein (GFAP) analysis in acute stroke: feasibility and diagnostic potential
C	Thu, June 12	08:00 - 09:00	Room 210	Child Neurology (CACN) Mini-Platforms
Moderator: Hugh McMillan C.1 Cognitive profile in pediatric seronegative autoimmune encephalitis C.2 Dexamethasone induced p57-mediated quiescence contributes to chemotherapy resistance in sonic hedgehog medulloblastoma C.3 Exploring reduced incidence of pediatric neuro-autoimmune disorders during COVID-19 restrictions C.4 Clinical, radiological, and etiological features in a cohort of 94 patients with schizencephaly C.5 The generation of alternative transcripts as a method of regulating phosphorylation in Sonic Hedgehog (Shh) Subtype Medulloblastoma (MB) C.6 Efficacy and safety of mTOR inhibitor therapy in a Canadian paediatric tuberous sclerosis complex cohort C.7 Design and implementation of individualized Acute Seizure Action Plans (ASAP): a quality improvement study
D	Thu, June 12	08:00 - 09:00	Room 203	Clinical Neurophysiology (CSCN) Mini-Platforms
Moderator: Michelle Mezei D.1 Quality of life in people with epilepsy living in Canada D.3 Self-reported autonomic nervous system dysfunction among people with drug-resistant focal epilepsy D.4 International consensus recommendations for the management of glucocorticoid complications in neuromuscular disease D.5 Efgartigimod treatment in participants with anti-acetylcholine receptor seronegative generalized myasthenia Myasthenia Gravis clinical studies D.6 Changes in intravenous or subcutaneous immunoglobulin usage before and after efgartigimod initiation in patients with Myasthenia Gravis D.7 Efgartigimod impact on I-RODS daily activity assessment in chronic inflammatory demyelinating polyneuropathy: post hoc analysis of Registrational ADHERE Study
E	Thu, June 12	08:00 - 09:00	Room 204	Neuroradiology (CSNR) Mini-Platforms
Moderator: Jai Shankar E.1 The role of the glymphatic system in the neurodegeneration associated to Multiple Sclerosis E.2 Isolated restricted diffusion at admission predicts survival in patients of glioblastoma (IRD-GB) – a prospective pilot study E.3 Behind the brain’s veil: unraveling the neuroimaging mysteries of CNS Balamuthia mandrillaris E.4 Safety and outcomes of middle meningeal artery embolization for pseudoaneurysms and aneurysms: a systematic review E.5 Does administration of iodinated contrast for CT-imaging modalities impact renal function? E.6 Return to work after aneurysmal subarachnoid hemorrhage: a systematic review of the literature and meta-analysis
F	Thu, June 12	08:00 - 09:00	Room 202	Neurosurgery (CNSS) Mini-Platforms
Moderator: Joseph Megyesi F.1 Validation and next-generation update of a DNA methylation-based recurrence predictor for meningioma: a multicenter prospective study F.2 Single cell CRISPR/Cas-9 lineage tracing reveals fitness axis in glioblastoma F.3 fMRI-based deep brain stimulation programming: a blinded, crossover clinical trial F.4 Risk factors for 30-day postoperative infection in pediatric ventricular shunts for hydrocephalus F.5 CHange in Optic nerve sheath diameter and Optic disc elevation and risk of Shunt failure in the pediatric Emergency department (CHOOSE study) F.6 Quality improvement in neurosurgery: the dramatic impact of the spine assessment clinic in reducing post-op emergency department visits F.7 Chromosome 1p loss and 1q gain are highly prognostic and can inform WHO grading of meningioma
P01	Mon, June 9	10:45 - 11:45	Poster Station 1 (Rideau Canal Atrium)	Neuromuscular Disease and EMG
Moderator: Fraser Moore P.101 Miglustat: a first-in-class enzyme stabiliser for late-onset Pompe Disease P.102 Clinical predictors of disease progression and survival in ALS: insights from the Canadian Neuromuscular Disease Registry P.103 Effectiveness and safety of ravulizumab in generalized Myasthenia Gravis (gMG): Updated analysis from a global registry P.104 A portrait of generalized Myasthenia Gravis in Canada: analysis of the Adelphi MG II disease specific programme P.105 Therapeutic options for changing the course of disease in generalized myasthenia gravis (gMG) and fiscal consequences for Canadian governments P.106 Investigating the bioequivalence, injection speed, and usability of subcutaneous efgartigimod PH20 administration using a prefilled syringe P.107 Early and sustained response over time with zilucoplan in generalised Myasthenia Gravis: 120-week post hoc analysis of RAISE-XT P.109 Pediatric quadriplegic CIDP: an update P.110 A case of refractory NF155 paranodopathy with near complete sponteneous recovery
P02	Mon, June 9	10:45 - 11:45	Poster Station 2 (Rideau Canal Atrium)	MS / Neuroinflammatory Disease
Moderator: Maryam Nouri P.010 Interim efficacy and safety results from the ongoing phase 3 CHAMPION-NMOSD trial of ravulizumab in adults with AQP4-Ab+ NMOSD P.011 Measuring cord blood b cells in neonates with possible exposure in utero to Anti-B cell therapies P.013 Psychosocial Impact of COVID-19 pandemic among Omanis with Multiple Sclerosis: a single tertiary center experience P.014 Decision-making in the use of corticosteroids for treating multiple sclerosis relapses: a retrospective study from a single Canadian center P.015 Analysis of Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibodies using live cell-based assay in a reference laboratory with over 6,000 tests P.016 Secondary immunodeficiencies in ocrelizumab - versus rituximab-treated persons with relapsing Multiple Sclerosis P.017 EBNA1 titres are elevated in radiologically isolated syndrome and correlate with plasma GFAP P.018 24-year-old woman post-partum with subacute paresthesias and facial diplegia
P03	Mon, June 9	10:45 - 11:45	Poster Station 3 (Rideau Canal Atrium)	Stroke 1
Moderator: Michel Shamy P.044 The impact of working hours on rapid GFAP measurement in acute stroke: evaluation of sampling bias in an ongoing prospective study P.045 Prevalence of right-to-left shunting in stroke occurrence of patients with active cancer P.046 Impact of telemedicine evaluation among ischemic stroke patients transferred for endovascular thrombectomy: data from the OPTIMISE registry P.047 Optimizing workflow of the initial patient visit to the stroke prevention clinic P.048 Cost-effectiveness of tenecteplase compared to alteplase for acute ischemic stroke from a Canadian perspective P.050 Mapping motor pathways with transcranial magnetic stimulation to predict functional outcomes in non-human primate models of chronic stroke P.128 Evaluation of endovascular access complexity on stroke patient’s initial imaging: an agreement study
P04	Mon, June 9	10:45 - 11:45	Poster Station 4 (Rideau Canal Atrium)	Other Child Neurology
Moderator: Sunita Venkateswaran P.081 Real-world benefits and tolerability of trofinetide for the treatment of Rett Syndrom: interim analysis of the LOTUS study P.063 Pediatric status dystonicus: 10-year experience at a single tertiary children’s hospital P.082 Real-world benefits and tolerability of trofinetide for the treatment of pediatric and adult patients with Rett Syndrom: the LOTUS study P.079 Body image in youth and adolescents with CP living in Ontario P.080 Head circumference values among Inuit children in Nunavut, Canada: a retrospective cohort study P.083 A novel mutation in YARS2 gene in a patient with MLASA P.070 Delay to diagnosis of Duchenne muscular dystrophy P.071 The value of genetics, biopsy and EMG in diagnosing congenital myopathies P.076 3-year Clinical Lessons Learned from the Alberta Spinal Muscular Atrophy Newborn Screening (SMA-NBS) P.084 Epidemiology and burden of illness in patients with Rett Syndrome in Ontario, Canada
P.05	Mon, June 9	10:45 - 11:45	Poster Station 5 (Trillium Ballroom)	Neurocritical Care / Neurotrauma
Moderator: Draga Jichici P.067 Transcranial doppler use in pediatric endovascular thrombectomy post large vessel obstruction secondary to infective endocarditis P.068 A proposed protocol for treatment of acute necrotizing encephalopathy of childhood at Stollery Children's Hospital P.026 Structural deficits with preserved kinematic performance after sport-related concussion P.113 Neurophysiological effects of repetitive non-concussive impacts in collegiate football players P.023 Impact of repeated nonconcussive hits on neurophysiological parameters in collegiate football athletes P.164 Early versus late initiation of chemical venous thromboembolism prophylaxis in adult patients with severe traumatic brain injury: a systematic review and meta-analysis P.125 Value of CTneck angiography and expanded Denver Criteria in assessing blunt cerebrovascular injury (BCVI) in blunt cervical trauma, assaults, and strangulation P.020 Transcranial doppler for risk assessment of subarachnoid hemorrhage
P06	Mon, June 9	10:45 - 11:45	Poster Station 6 (Trillium Ballroom)	Neuroimaging
Moderator: Cameron Elliott P.166 Rate and clinical utility of early postoperative CT head in adult craniotomy P.167 The accuracy of MRI reports in detecting neurovascular conflict in hemifacial spasm P.168 Radiographic factors associated with success of endoscopic third ventriculostomy (ETV): retrospective cohort study P.120 Intracranial extension of temporomandibular joint (TMJ) lesions: A review of neuroimaging and clinical features P.132 The role of large language models in neuroradiology: a scoping review and thematic analysis P.122 Radiologico-pathologic heterogeneity and complexity of polymicrobial brain abscesses P.123 Decoding the brachial plexus : from fundamentals to advances - anatomy, imaging and pathologies P.121 Bridging the evidence gap: RAG-enabled LLMs in neuroimaging decision support P.021 Hyperglycemia presenting with visual hallucinations due to occipital lobe seizures P.165 Comparison of preoperative diffusion tensor imaging tractography platforms for intrinsic brain lesions
P07	Mon, June 9	10:45 - 11:45	Poster Station 7 (Trillium Ballroom)	Neuro-oncology 1
Moderator: Joseph Megyesi P.137 Long term outcome of central neurocytoma: a multicenter study of eleven tertiary care centers P.138 Survival and recurrence outcomes for primary meningeal melanocytic neoplasms of the central nervous system in British Columbia P.139 Predicting pituitary gland location during endoscopic endonasal surgery using machine learning model P.144 Artery of Percheron Infarction following endoscopic transsphenoidal surgery: a case series and literature review P.153 Predictors and clinical outcomes of postoperative cerebro spinal fluid leak after endoscopic endonasal skull base surgery P.154 The endoscopic endonasal transclival approach for the treatment of skull base lesions P.158 Molecular characterization of RTOG-0539 risk groups in meningioma: insights into radiotherapy response and tumor biology P.160 Convexity dermoid cyst: a case report and review of the literature
P08	Mon, June 9	10:45 - 11:45	Poster Station 8 (Trillium Ballroom)	Neuro-oncology 2
Moderator: Amparo Wolf P.145 The role of 5-ALA Fluorescence-guided surgery in non-glioma pathologies P.146 Factors affecting local control of resected brain metastases after single-fraction stereotactic radiosurgery: a systematic scoping review P.147 Endoscopic transorbital approach to the skull base: a single centre 8 year experience P.149 Two cases of vestibular nerve hybrid nerve sheath tumours and literature review P.151 The development of an image-guided, multi-biopsy tool for neurosurgical applications P.161 Postoperative visual deterioration after endoscopic pituitary adenoma resection: predictors, management, and long-term sequelae P.143 Eligibility criteria in glioma clinical trials: a systematic review and meta-analysis on selectivity, generalizability, and real-world applicability
P09	Mon, June 9	10:45 - 11:45	Poster Station 9 (Trillium Ballroom)	Other Neurosurgery / Neurovascular
Moderator: Stuart McGregor P.184 Synthetic neurosurgical data generation using large language models P.186 Trends in the management of scalp aplasia cutis congenita P.191 Factors affecting access to neurosurgical care in diverse communities in Canada: a qualitative scoping review P.029 Personalized locomotor training with non-invasive spinal cord stimulation for functional recovery after spinal cord injury P.193 Persistent central hypercortisolemia following pituitary stalk tumor resection: case lesson P.196 Leading the way: an overview of leadership in Canadian academic neurosurgery P.126 Isolated intraventricular hemorrhage presenting as reversible cerebral vasoconstriction syndrome P.129 Carotid artery coil extrusion: a rare but potential complication of endovascular coiling in post radiated neck P.131 Mapping the neurointerventional radiology landscape in Canada: trends in growth, accessibility, and training opportunities
P10	Wed, June 11	10:45 - 11:45	Poster Station 1 (Rideau Canal Atrium)	Other Adult Neurology
Moderator: Cecile Phan P.036 Delayed orthostatic tachycardia – is the time frame for postural orthostatic tachycardia syndrome arbitrary? P.033 Long-term efficacy of Efgartigimod PH20 SC in patients with chronic inflammatory demyelinating polyneuropathy: interim results from the ADHERE+ study P.031 Consistency of objective sleep maintenance data in Chinese and North American/European subjects with insomnia in lemborexant phase 3 studies P.032 Accessing ambulatory care in neurology: understanding and addressing demand in Calgary P.034 Understanding and implementing multidisciplinary care for patients with neurofibromatosis 1 in British Columbia P.035 Using deferred consent in emergency research: an evaluation of two prospective CT-perfusion studies P.030 Impact of lemborexant on daytime sleepiness/alertness in participants with comorbid insomnia and mild obstructive sleep apnea P.012 Myelin water imaging in Anti-NMDA receptor autoimmune encephalitis; a pilot study
P11	Wed, June 11	10:45 - 11:45	Poster Station 2 (Rideau Canal Atrium)	Epilepsy and EEG (CACN)
Moderator: Anita Datta P.051 Epilepsy Absence of children, A Guinean cohort of 69 cases P.052 SYNGAP-1 developmental and epileptic encephalopathy: utility of corpus callosotomy and neuromodulation P.053 Biallelic SCN1A variants with divergent epilepsy phenotypes P.055 Novel pipeline for triage of variant of uncertain significance reclassification in epilepsy genomics P.057 A review of a twenty-seven year experience with the Ketogenic diet: lessons learned and moving forward P.058 Ketogenic diet for medication refractory infantile spasms in patients with Down syndrome: experience at the Children’s Hospital of Eastern Ontario P.059 Exome-based testing for seizure indications captures a broader range of diagnostic genes and more diagnostic variants than provincially-funded epilepsy panels P.061 Exploring emergency department visits in adolescents with epilepsy and mild intellectual disabilities (MID)
P12	Wed, June 11	10:45 - 11:45	Poster Station 3 (Rideau Canal Atrium)	Stroke 2 / Neurovascular and Neurointerventional
Moderator: Jeanne Teitelbaum P.027 Sex differences in symptomatic intracranial hemorrhage and procedural complications after endovascular thrombectomy: Analysis of the OPTIMISE registry P.028 Tenecteplase for treatment of acute ischemic stroke in the extended time window, a review of current data P.179 Delays in transfer of rural aneurysmal subarachnoid hemorrhage patients in British Columbia P.181 Surgical results with low-grade arteriovenous malformations: a single center 16-year experience P.182 Intracranial-intracranial bypass strategies for the treatment of complex intracranial aneurysms P.183 Anesthetic strategies for mechanical thrombectomy: a single-center retrospective review P.114 The impact of pre-stroke frailty on stroke rehabilitation outcomes: a retrospective cohort study P.115 Regenerative white matter effect of neurod1-based gene therapy in non-human primate stroke model P.116 Improving the NeuroD1-AAV-based gene therapy intracerebral injection protocol for optimal neuronal recovery
P13	Wed, June 11	10:45 - 11:45	Poster Station 4 (Rideau Canal Atrium)	Dementia and Cognitive Disorders / Movement Disorders
Moderator: Andrew Kirk P.001 Predictors of long-term care admission in patients presenting to the rural and remote memory clinic in Saskatchewan P.002 Comprehensive validation of two commercial immunoassays for the biological diagnosis of Alzheimer's Disease a laboratory diagnostic test P.003 Assessing the impact of attitudes toward aging on cognition and Alzheimer's Disease biomarkers in older adults P.005 Real-world evidence of Lecanemab use in the United States P.006 Cost-effectiveness of Lecanemab for the treatment of early Alzheimer's Disease: a Canadian societal perspective P.007 Tailoring a mindfulness intervention as a therapeutic intervention for mild cognitive impairment P.064 MOXIe clinical trial overview of omaveloxolone for patients with Friedreich ataxia P.008 Developing the Calgary Functional Movement Disorder Registry: a preliminary report and baseline patient characteristics P.009 Women’s health in Parkinson’s Disease
P14	Wed, June 11	10:45 - 11:45	Poster Station 5 (Trillium Ballroom)	Other Neurosurgery 1
Moderator: Patrick J. McDonald P.207 Endoscopic odontoidectomy for anterior cervicomedullary junction decompression P.205 Pain has a significant impact on post-operative quality of life outcomes in patients requiring surgical intervention for degenerative cervical myelopathy P.206 An examination of risk factors and outcomes of iatrogenic dural tears in southern New Brunswick P.208 Open and minimally invasive in-vivo accuracy of pedicle screws with an autonomous robotic system P.134 Occipital nerve stimulation for refractory craniofacial pain P.135 Impact of brainstem lesion location on symptoms and treatment response in Multiple Sclerosis-Associated Trigeminal Neuralgia P.169 Canadian neurosurgical attrition rate: a qualitative exploration P.171 A psychological assessment tool to improve quality of life in neurosurgical residents: a prospective cohort study P.024 Supporting the transition from trainee to independent neurologist: development of a transition-to-practice clinic for senior neurology residents
P15	Wed, June 11	10:45 - 11:45	Poster Station 6 (Trillium Ballroom)	Spine and Peripheral Nerve Surgery / Other Neurosurgery 2
Moderator: Stuart McGregor P.187 Development of benign enlargement of subarachnoid spaces growth charts P.197 To stave or not to stave? The impact of barrel-stave osteotomy on cephalometric measurements in endoscopic repair of sagittal craniosynostosis P.198 Outcomes and connectivity changes in treatment-resistant OCD after MR-guided focused ultrasound capsulotomy P.199 Management of ruptured arachnoid cysts with hemorrhage: a bayesian network analysis P.201 Normal pressure hydrocephalus concomitant with Progressive Supranuclear Palsy: an autopsy-confirmed case and review of the literature P.202 Management of subdural hematoma as a complication of shunting in normal pressure hydrocephalus P.192 Resident wellness and burnout in the University of Alberta Neurosurgery Residency Program – a quality improvement study P.176 Latent home time trajectories for isolated moderate to severe traumatic brain injury survivors: a data-driven method identifies distinct outcome phenotypes P.177 Artificial intelligence-based outcome prediction for moderate to severe traumatic brain injury: a systematic review and methodological appraisal
P16	Wed, June 11	10:45 - 11:45	Poster Station 7 (Trillium Ballroom)	Neuro-oncology 3
Moderator: Joseph Megyesi P.152 Local control and survival in brain metastases treated with cavity directed gamma knife radiosurgery: a single center retrospective study P.150 Spontaneous regression of vestibular schwannoma: a clinical and radiographic characterization P.142 Development and validation of a molecular classifier of meningiomas P.159 Negative feedback between Ezh2 and Cyclin D1 governs granule neuron precursor fate P.141 Spontaneous resolution of a left temporal extra-axial lesion: case report P.162 The challenge of Giant Olfactory Groove Meningiomas: long-term outcome and predictive modeling P.118 A rare case of eccrine carcinoma with perineural metastases - a rare cause of facial pain P.155 Endoscopic endonasal approaches for the resection of anterior skull base meningiomas P.156 The role of indocyanine green fluorescence in the treatment of pituitary tumors
P17	Wed, June 11	10:45 - 11:45	Poster Station 8 (Trillium Ballroom)	Epilepsy and EEG (CSCN)
Moderator: JP Appendino P.085 Exploring the efficacy and safety of perampanel in epilepsia partialis continua: a case series P.086 Randomized controlled trial evaluating virtual reality exposure therapy on epilepsy/seizure-specific interictal anxiety in people with epilepsy P.087 Methods for representing dipole distribution in high-density EEG source localization for focal epilepsy: a systematic analysis P.090 Investigating deep brain stimulation parameters for drug resistant epilepsy treatment: a literature review P.111 Investigation of clinical features, EEG findings, and brain imaging in psychiatric patients with epilepsy at Razi Psychiatric Hospital P.091 Parameterized short-segment EEG improves neurological recovery prediction in patients with severe brain injury P.089 Multiscale analysis of mesial temporal lobe epilepsy: Anatomo-Electrophysio-pathologic differentiation
P18	Wed, June 11	10:45 - 11:45	Poster Station 9 (Trillium Ballroom)	Neuromuscular Disease and EMG
Moderator: Katie Beadon P.100 A randomized, open-label study on the effect of Nipocalimab on vaccine responses in healthy participants P.094 A phase 1, multicenter, randomized, placebo-controlled, multiple ascending dose study to evaluate the safety and tolerability of AMX0114 in ALS (LUMINA) P.096 Final pooled analysis of efficacy and safety of rozanolixizumab cycles in patients with generalised myasthenia gravis: MycarinG and open-label extension studies P.098 Does single fiber EMG (SFEMG) pair number influence the outcome of patients initially referred for possible myasthenia gravis (MG)? P.108 Utility of skin Biopsy/IENFD in management of hATTR-PN P.099 Post-hoc evaluation of the clinical effects of nipocalimab, a neonatal fragment crystallizable blocker, over time in the Vivacity MG3 study P.072 Safety and effectiveness of Nipocalimab in adolescent participants in the open label phase 2/3 Vibrance-mg clinical study